Literature DB >> 6941410

Effect of aspirin on the human stomach in normals: endoscopic comparison of damage produced one hour, 24 hours, and 2 weeks after administration.

J C O'Laughlin, J W Hoftiezer, K J Ivey.   

Abstract

We studied the effects of regular aspirin on the human stomach by endoscopy in 15 volunteers divided equally into three groups. Each had a normal baseline endoscopy. In Group I, two aspirin or placebo tablets were administered suspended in 100 cc of water and endoscopic assessment made over on hour, at four hours, and 24 hours. In Group II, in a two way cross-over, blinded study we compared the effects of 24 hours' ingestion of 3.25 g of aspirin and placebo. Group III subjects received aspirin, two tablets four times daily for two weeks. In Group I, multiple petechiae (p less than 0.05) developed in the fundus and antrum by one hour and were still visible at 24 hours in 80%. In Group II, aspirin produced multiple antral erosions (p less than 0.05 vs. placebo) in all subjects and duodenal erosions in half. Antral and duodenal petechiae were common. In Group III, all subjects developed antral erosions (p less than 0.05 vs. control) and 50% duodenal erosions but only on subject developed petechiae. Acute aspirin administration appears to cause predominantly petechial hemorrhage in the fundus and antrum while longer term administration causes antral and duodenal erosions. Regular aspirin in recommended doses for one hour, 24 hours and two weeks produces endoscopically visible gastroduodenal damage in the majority of normal subjects.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6941410

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  18 in total

Review 1.  Are perioperative nonsteroidal anti-inflammatory drugs ulcerogenic in the short term?

Authors:  H Kehlet; J B Dahl
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 2.  Mechanisms of NSAID-induced gastroenteropathy.

Authors:  A H Price; M Fletcher
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 3.  Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use.

Authors:  J Nash; L Lambert; M Deakin
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

4.  Gastric protection by misoprostol against 1300 mg of aspirin. An endoscopic study.

Authors:  F E Silverstein; M B Kimmey; D R Saunders; D S Levine
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

Review 5.  Non-steroidal anti-inflammatory agents and the gastrointestinal tract.

Authors:  K W Somerville; C J Hawkey
Journal:  Postgrad Med J       Date:  1986-01       Impact factor: 2.401

6.  Cimetidine decreases indomethacin induced duodenal mucosal damage in patients with acute musculoskeletal disorders.

Authors:  R Stalnikowicz; D Pollak; A Eliakim; D Wengrower; A Fich; E Goldin; M Ligumsky; D Rachmilewitz
Journal:  Gut       Date:  1988-11       Impact factor: 23.059

Review 7.  Gastrointestinal effects of aspirin.

Authors:  Carlos Sostres; Angel Lanas
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06-07       Impact factor: 46.802

8.  Reduction of endoscopically assessed acute aspirin-induced gastric mucosal injury with cimetidine.

Authors:  M B Kimmey; F E Silverstein; D R Saunders; R C Chapman
Journal:  Dig Dis Sci       Date:  1987-08       Impact factor: 3.199

Review 9.  Gastrointestinal intolerance and bleeding with non-narcotic analgesics.

Authors:  K J Ivey
Journal:  Drugs       Date:  1986       Impact factor: 9.546

10.  Gastro-duodenal injury associated with intake of 100-325 mg aspirin daily.

Authors:  R Oren; M Ligumsky; J Lysy; J Gonzales; J Zimmerman
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.